Partners

Eberhard Karl's University Tübingen

The Biomedical magnetic resonance, (BMMR) department, at the Medical Faculty of the Eberhard Karl’s University in Tübingen, (Germany), led by Dr. Gisela Hagberg, has a strong experience in clinical studies at Ultrahigh Magnetic Field strengths. Since December 2012, over forty patients have successfully participated in clinical studies at 9.4T and quantitative, high resolution methods capable of revealing pathology related alterations of tissue structure have been developed by exploiting recent developments in UHF technology with clinical validity also at 3T. The group also explores the diagnostic use of quantitative mapping of T1, R2*, and Magnetic Susceptibility (QSM) for investigating Alzheimer’s disease in vivo and in post mortem samples. 

IRCCS Stella Maris Foundation

The MR group hosted by the IRCCS Stella Maris in Pisa, Italy, has a long history of applying highly advanced MRI methods for clinical research. Since 2015, the MR group, led by Prof. Michela Tosetti, merged into the Medical Physics and Magnetic Resonance Laboratory, a complex unit between IRCCS Stella Maris and IMAGO7 Foundation. IMAGO7 Foundation is a consortium for scientific research in the field of magnetic resonance (MR) at ultra­high static field and hosts the first, and only, 7T scanner for human studies in Italy. Since its inauguration in 2012, over 450 subjects were investigating at 7T, including healthy volunteers and patients and several papers were published demonstrating the clinical usefulness of advanced techniques at UHF. 

CUDIM

The Centro Uruguayo de Imagenología Molecular in Montevideo Uruguay, is headed by Prof Henry Engler who pioneered the use of 11C­PIB for detecting and quantifying amyloid burden in Alzheimer’s. CUDIM has gathered an interdisciplinary team of highly skilled scientists working in a high­tech environment equipped to perform everything from radiotracer synthesis to clinical studies.